Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	1.21	25.65	25.34
Graham Fair Price	-10.73	3.73	4.17
PEG	-129.33	-0.68	-0.30
Price/Book	31.99	1.00	0.76
Price/Cash Flow	inf	0.00	68.70
Prices/Earnings	43.33	8.51	5.94
Price/Sales	23.98	8.45	6.82
Price/FCF	inf	0.00	68.70
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-1.09	0.40	0.40
ROA	-14.03	< 0.005	< 0.005
ROE	0.03	0.03	-7.91
ROIC	0.01	0.01	10.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	-339.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.24	< 0.005	97.17
EPS QOQ	-0.20	-0.12	37.50
FCF QOQ	0.03	0.00	inf
Revenue QOQ	< 0.005	< 0.005	-47.30
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.98	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.69	0.62	-9.32
Quick Ratio	16.82	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4.93	4.58	-6.97
Cash	5.14	5.88	14.32
Capex	0.00	n.A.	n.A.
Free Cash Flow	0.05	n.A.	n.A.
Revenue	0.55	0.54	-0.96
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	16.80	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.32	6.79	-34.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating